STING1 and neoplasm: Stimulators of interferon genes (STINGs), such as cyclic dinucleotides (CDNs), stimulate dendritic cell maturation and the cross-presentation of tumor antigens for subsequent T-cell priming [134] via intratumoral injection to obtain an effective anti-cancer treatment [135].